A trial is currently being conducted into a vaccine for B Cell Lymphoma. The Kvax vaccine trial is recruiting dogs who have been diagnosed with B Cell Lymphoma who have not received any treatment.
The blinded study will consist of three groups of dogs. One group of dogs will receive a placebo, another group will receive 4 KVAX vaccinations and the third group will receive 10 KVAX vaccinations. Neither the owner or the vet will know which dogs are in which group.
Dogs will be given CHOP the standard treatment for dogs with this cancer and once in remission they will be given the vaccine. . The injections will be free. Owners will have to pay for the chemotherapy and any other radiology or tests that may be required as part of this trial.